
Radio and PodcastLive Radio & Podcasts
FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast media for medical imaging
FDA Drug Safety Podcasts by U.S. Food and Drug Administration, Center for Drug Evaluation and Research
Listen to an audio podcast of the March 30, 2022 FDA Drug Safety Communication Iodinated Contrast Media
Related Episodes
Continue listening to more episodes from FDA Drug Safety Podcasts.


FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause
Sep 20, 2024 - 3:30
Listen to an audio podcast of the September 12th, 2024 FDA Drug Safety Communication on rare occurrence o...

FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)
Feb 6, 2024 - 4:00
Listen to FDA Drug Safety Podcast titled, FDA adds Boxed Warning for increased risk of severe hypocalcemi...

Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
Jan 26, 2024 - 3:30
Listen to FDA Drug Safety Podcast, FDA's preliminary evaluation has not found evidence that use of GLP-1...

FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)
Dec 8, 2023 - 5:05
Listen to an audio podcast of the November 28, 2023, FDA Drug Safety Communication, FDA warns of rare but...

FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions
May 31, 2023 - 5:30
Listen to an audio podcast of the May 11, 2023, FDA Drug Safety Communication on warnings to improve safe...

FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use
May 10, 2023 - 7:30
Listen to an audio podcast of the April 13, 2023, FDA Drug Safety Communication, FDA updates prescribing...

FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)
Dec 16, 2022 - 4:00
FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Pro...